Equity Analysis /
Bangladesh

BANGLADESH PHARMA : Still growing; more value in SQUARE (BUY) than BXPHAR (HOLD)

    Asif Khan
    Asif Khan

    Banks Analyst - South Asia

    Tellimer Research
    7 February 2017
    Published by